Merck: Income more than doubles

Comment on this story

MERCK’S second-quarter profit more than doubled, the company reported yesterday, as the second-biggest US drug maker by sales cut costs and benefited from a one-time gain on the sale of a business interest. Net income rose to $2 billion (R21bn), or 68c a share, from $906 million a year earlier, Merck said. Earnings a share excluding one-time items were 85c, beating the 81c average of 16 analysts’ estimates. Last year Merck said it would fire 8 500 workers in a move to save $1bn a year. Since then, it has been reprioritising its research. In the quarter to June it cut research and development costs by 21 percent to $1.7bn. Merck bought Idenix Pharmaceuticals in June for its experimental hepatitis C drug. – Bloomberg


sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines